Telbivudine myopathy in a patient with chronic hepatitis B

ISSN： 2210-7703

Source： International Journal of Clinical Pharmacy, Vol.34, Iss.3, 2012-06, pp. : 422-425

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Telbivudine for Chronic Hepatitis B. A Review

Anti-Infective Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Infective Agents), Vol. 7, Iss. 4, 2008-10 ,pp. : 245-248

Bentham Science Publishers

Access to resources Recommend Favorite

Telbivudine for chronic hepatitis B: the GLOBE trial

By Yuen Man-Fung Lai Ching-Lung

Future Virology, Vol. 3, Iss. 4, 2008-07 ,pp. : 317-323

Future Medicine

Access to resources Recommend Favorite

Continuous venovenous hemodiafiltration for hyperlactatemia caused by telbivudine in a patient with chronic hepatitis B: A case report and update review

Journal of Digestive Diseases, Vol. 16, Iss. 3, 2015-03 ,pp. : 164-167

John Wiley & Sons Inc

Access to resources Recommend Favorite

A review of telbivudine for the management of chronic hepatitis B virus infection

By Lui Yanni YN Chan Henry LY

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 10, 2008-10 ,pp. : 1351-1361

Informa Healthcare

Access to resources Recommend Favorite

Telbivudine: A Review of its Use in Compensated Chronic Hepatitis B

By McKeage Kate Keam Susan J.

Drugs, Vol. 70, Iss. 14, 2010-10 ,pp. : 1857-1883

Adis International

Access to resources Recommend Favorite